Related Experiment Video
Updated: Aug 21, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
[Aromatase inhibitors--new applications in gynecology]
A Shrim1, S E Elizur, M E Beiner
1IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Abstract:
P-450 aromatase inhibitors, designed for suppressing estradiol production, were first approved for the treatment of advanced breast cancer. Recent studies have provided evidence that aromatase inhibitors may be effective in the short term for induction of ovulation and in the long-term for treatment of endometriosis. Based on current data, the role of aromatase inhibitors in the management of various gynecological conditions may soon be widely determined.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Oral Hypoglycemic Agents: Biguanides and Glitazones
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Antiviral Nucleoside Inhibitors
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists